
Results
211
211 companies
CSPC Pharmaceutical Group
Market Cap: HK$96.2b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.40
7D
-0.4%
1Y
-1.9%
Mineralys Therapeutics
Market Cap: US$2.4b
A biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$27.52
7D
0.9%
1Y
106.3%
Cogent Biosciences
Market Cap: US$6.5b
A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.
COGT
US$39.64
7D
2.9%
1Y
218.4%
Tarsus Pharmaceuticals
Market Cap: US$2.4b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$57.26
7D
2.0%
1Y
35.2%
China Resources Double-Crane PharmaceuticalLtd
Market Cap: CN¥17.6b
China Resources Double-Crane Pharmaceutical Co.,Ltd.
600062
CN¥17.16
7D
-0.5%
1Y
-11.0%
Xiamen Amoytop Biotech
Market Cap: CN¥24.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.36
7D
1.5%
1Y
-21.9%
InventisBio
Market Cap: CN¥15.0b
A clinical stage biotech company, focuses on areas of oncology, autoimmune diseases, and metabolic disorders to address unmet medical needs in China.
688382
CN¥25.56
7D
1.0%
1Y
-42.7%
Joincare Pharmaceutical Group IndustryLtd
Market Cap: CN¥18.5b
Joincare Pharmaceutical Group Industry Co.,Ltd.
600380
CN¥10.48
7D
-0.4%
1Y
-14.4%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥41.6b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥25.16
7D
-0.2%
1Y
-20.4%
BGI Genomics
Market Cap: CN¥14.1b
Engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally.
300676
CN¥37.49
7D
0.3%
1Y
-26.9%
Laurus Labs
Market Cap: ₹860.1b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,577.80
7D
1.5%
1Y
91.8%
Genscript Biotech
Market Cap: HK$32.1b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$15.62
7D
5.4%
1Y
-14.0%
Keymed Biosciences
Market Cap: HK$25.6b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China, the United States, and the United Kingdom.
2162
HK$83.60
7D
-4.0%
1Y
44.1%
LigaChem Biosciences
Market Cap: ₩3.4t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩93,900.00
7D
-15.4%
1Y
-34.9%
InSilico Medicine Cayman TopCo
Market Cap: HK$25.3b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$45.44
7D
-10.9%
1Y
n/a
Ipca Laboratories
Market Cap: ₹456.4b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.
IPCALAB
₹1,788.50
7D
-4.8%
1Y
22.5%
Dr. Reddy's Laboratories
Market Cap: ₹1.0t
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,183.00
7D
-3.8%
1Y
-5.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.8b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€54.70
7D
2.0%
1Y
3.4%
Veradermics
Market Cap: US$4.4b
A clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.
MANE
US$109.49
7D
-0.6%
1Y
n/a
Agios Pharmaceuticals
Market Cap: US$2.4b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$37.36
7D
-6.4%
1Y
-5.8%
Crinetics Pharmaceuticals
Market Cap: US$8.8b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$83.90
7D
0.2%
1Y
175.4%
Pharmaron Beijing
Market Cap: CN¥65.5b
Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.
300759
CN¥39.76
7D
-1.3%
1Y
46.2%
Yuhan
Market Cap: ₩5.2t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩70,700.00
7D
1.7%
1Y
-43.5%
WuXi AppTec
Market Cap: CN¥376.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥125.90
7D
-4.3%
1Y
49.8%
United Laboratories International Holdings
Market Cap: HK$18.1b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.22
7D
-0.1%
1Y
-42.9%
Walvax Biotechnology
Market Cap: CN¥21.8b
Engages in the research and development, manufacture, and distribution of vaccines in China and internationally.
300142
CN¥13.49
7D
-2.2%
1Y
16.5%
Gland Pharma
Market Cap: ₹409.0b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹2,439.10
7D
-1.1%
1Y
19.7%
WuXi XDC Cayman
Market Cap: HK$70.7b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$54.75
7D
-12.6%
1Y
2.1%
Grand Pharmaceutical Group
Market Cap: HK$18.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.32
7D
1.1%
1Y
-43.4%
Haw Par
Market Cap: S$3.6b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$16.22
7D
-3.6%
1Y
26.8%
Hangzhou Tigermed Consulting
Market Cap: CN¥39.7b
Provides contract research organization services in the People’s Republic of China and internationally.
300347
CN¥49.29
7D
-5.0%
1Y
-14.4%